PubRank

Claire Rekacewicz

Author PubWeight™ 24.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med 2011 7.13
2 Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA 2002 2.91
3 Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial. Trials 2013 1.91
4 Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316. J Infect Dis 2002 1.62
5 Feasibility of early infant diagnosis of HIV in resource-limited settings: the ANRS 12140-PEDIACAM study in Cameroon. PLoS One 2011 1.30
6 Changing pattern of hepatitis C virus spread in rural areas of Egypt. J Hepatol 2005 1.19
7 Chronic hepatitis C virus infection: does it really impact health-related quality of life? A study in rural Egypt. Hepatology 2004 1.04
8 Serum alpha-foetoprotein level predicts treatment outcome in chronic hepatitis C. Antivir Ther 2007 1.01
9 Injection drug use is a risk factor for HCV infection in urban Egypt. PLoS One 2009 1.00
10 Surveillance of acute hepatitis C in Cairo, Egypt. J Med Virol 2005 0.96
11 Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4. J Med Virol 2009 0.95
12 HCV-related morbidity in a rural community of Egypt. J Med Virol 2006 0.95
13 Feasibility of antenatal and late HIV testing in pregnant women in Phnom Penh Cambodia: the PERIKAM/ANRS1205 study. AIDS 2002 0.91
14 Symptomatic acute hepatitis C in Egypt: diagnosis, spontaneous viral clearance, and delayed treatment with 12 weeks of pegylated interferon alfa-2a. PLoS One 2008 0.84
15 Evidence for a dominant major gene conferring predisposition to hepatitis C virus infection in endemic conditions. Hum Genet 2009 0.79
16 Surveillance system for HCV infection: testing a model based on blood banks. J Egypt Public Health Assoc 2007 0.76